CoChat

Prevalence of hereditary hemochromatosis in a Massachusetts corporation: Is Celtic origin a risk factor?

Open access
Smith, B N, Kantrowitz, W, Grace, N D, Greenberg, M S, Patton, T J, Ookubo, R, Sorger, K, Semeraro, J G, Doyle, J R, Cooper, A G, Kamat, B R, Maregni, L M, Rand, W M · 1997 · Hepatology
Cited by 69

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

The prevalence of homozygous hereditary hemochromatosis (HHC) is estimated at 1:250 in Caucasian adults. Little is known about ethnic subpopulations that might be at increased risk for this disease. HLA data have suggested a Celtic origin for HHC. Screening for HHC was offered to all employees of the Massachusetts Polaroid Corporation. Participants with a transferrin saturation of >55% or >45% and an elevated serum ferritin concentration on two screenings were referred for liver biopsy. The diagnosis of HHC was based on histological criteria, quantitative hepatic iron determination, hepatic iron index, and the phlebotomy requirement for iron depletion. Participants completed a questionnaire regarding their ethnic background. Two thousand two hundred ninety-four employees were screened, and 5 cases of HHC were detected. All 5 cases involved Caucasian men, yielding a prevalence of 1:395 for the Caucasian population. Four of the 5 cases were of 100% British-Irish ancestry based on the country of origin of their grandparents. Additional analysis revealed that the majority of grandparents of all 4 individuals came from Ireland or Wales. The exact two-tailed trend test showed a significant association of HHC with Celtic background (P = .012). The estimated cost of screening per patient identified was $18,041. Polaroid Corporation has a high representation of employees of British-Irish ancestry. Our data suggest that they are at high risk for developing HHC. A significant association of HHC with Celtic ancestry was found in this subpopulation, supporting the concept of a Celtic origin for this disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.510250622

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 69

Metadata

Authors
Smith, B. N., Kantrowitz, W., Grace, N. D., Greenberg, M. S., Patton, T. J., Ookubo, R., Sorger, K., Semeraro, J. G., Doyle, J. R., Cooper, A. G., Kamat, B. R., Maregni, L. M., & Rand, W. M.
Venue
Hepatology
Published
1997-06
Volume
25
Issue
6
Pages
1439-1446
ISSN
0270-9139 (ISSN-L)
OpenAlex
W1990839270
Cited by
69
References
2
FWCI
4.44
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevalence of hereditary hemochromatosis in a Massachusetts corporation: Is Celtic origin a risk factor? https://app.cochat.ai/papers/10.1002/hep.510250622
The paper
Smith, B. N., Kantrowitz, W., Grace, N. D., Greenberg, M. S., Patton, T. J., Ookubo, R., Sorger, K., Semeraro, J. G., Doyle, J. R., Cooper, A. G., Kamat, B. R., Maregni, L. M., & Rand, W. M. (1997). Prevalence of hereditary hemochromatosis in a Massachusetts corporation: Is Celtic origin a risk factor? Hepatology. https://doi.org/10.1002/hep.510250622

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.